Evidence map›Paper›PMID 25070796›Full record

ArticleNature genetics2014

miR-212 and miR-132 are dispensable for mouse mammary gland development.

Hiroyuki Kayo, Kotaro Kiga, Yoko Fukuda-Yuzawa, Sebastian Hedlund, Kazuyoshi Murakami, Inti A De La Rosa-Velazquez, Tokuhiro Kimura, Kouji Shimoda, Masanobu Tanabe, Taro Fukao

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Nature genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance.Frontiers in cell and developmental biology · 2018
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Hiroyuki Kayo1] Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. [2].
Kotaro Kiga1] Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. [2].
Yoko Fukuda-Yuzawa1] Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. [2].
Sebastian HedlundMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Kazuyoshi MurakamiMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Inti A De La Rosa-VelazquezMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Tokuhiro KimuraDepartment of Pathology, Yamaguchi University, Graduate School of Medicine, Yamaguchi, Japan.
Kouji ShimodaCenter for Animal Experiments, Keio University School of Medicine, Tokyo, Japan.
Masanobu TanabeDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Taro FukaoMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Max Planck Institute of Immunobiology and Epigenetics · DEKeio University · JPYamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell CommunicationAnimalsEpithelial CellsFemaleMammary Glands, AnimalMicroRNAsMicroRNAs

Identifiers

PMID25070796
OpenAlexW3145698515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.